Hyderabad, Oct. 5 -- Officials from the World Health Organisation (WHO) and an independent group of experts will meet next week to carry out a risk/benefit assessment and take a final decision on whether to grant 'Emergency Use Listing' to Hyderabad-based Bharat Biotech's Covaxin as a safe and effective vaccine against the COVID-19 virus.

"Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis & submitted additional info at WHO's request on 27 September. WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week," the WHO said in a series of tweets on Tuesday.

The 'Emergency Use Listing' process by the WHO and the Technical Advisory G...